Financials Oceania Healthcare Limited Australian S.E.

Equities

Market Closed - Australian S.E. Other stock markets 22:20:12 2024-06-26 EDT			5-day change	1st Jan Change
0.5 ^AUD	+1.01%		+1.01%	-23.37%

06-27	Transcript : Oceania Healthcare Limited - Shareholder/Analyst Call
06-27	Oceania Healthcare Limited Resolves Not to Pay a Final Dividend	CI

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	424.3	878.2	745.7	526	456.2	383.8	-	-
Enterprise Value (EV) ¹	746.3	878.2	1,116	1,081	456.2	947.6	886.1	890.2
P/E ratio	-31.4 x	9.28 x	12.1 x	33.2 x	14.7 x	5.64 x	4.86 x	3.94 x
Yield	5.07%	-	4.19%	4.38%	-	2.28%	4.33%	6.14%
Capitalization / Revenue	2.19 x	-	3.23 x	2.13 x	1.72 x	1.28 x	1.17 x	1.1 x
EV / Revenue	3.86 x	-	4.83 x	4.37 x	1.72 x	3.15 x	2.69 x	2.56 x
EV / EBITDA	11.8 x	-	14.6 x	13.5 x	5.52 x	9.6 x	8.16 x	7.53 x
EV / FCF	-	-	-9,851,707 x	-	-	-	-	-
FCF Yield	-	-	-0%	-	-	-	-	-
Price to Book	0.72 x	-	0.79 x	0.55 x	-	0.35 x	0.33 x	0.3 x
Nbr of stocks (in thousands)	614,892	686,112	710,205	720,555	724,155	724,212	-	-
Reference price ²	0.6900	1.280	1.050	0.7300	0.6300	0.5300	0.5300	0.5300
Announcement Date	20-07-22	21-05-21	22-05-19	23-05-23	24-05-23	-	-	-

¹NZD in Million²NZD

Estimates

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	193.6	-	231.1	247.2	265.5	300.7	329	347.7
EBITDA ¹	63.5	-	76.24	80.02	82.6	98.73	108.6	118.3
EBIT ¹	49	-	57.62	62.09	63.6	86.93	88.93	93.26
Operating Margin	25.31%	-	24.93%	25.12%	23.95%	28.91%	27.03%	26.82%
Earnings before Tax (EBT)	-28.3	-	-	-	-	-	-	-
Net income ¹	-13.6	85.53	61.13	15.45	31.5	64.1	92.66	105.6
Net margin	-7.02%	-	26.45%	6.25%	11.86%	21.32%	28.17%	30.36%
EPS ²	-0.0220	0.1380	0.0870	0.0220	0.0430	0.0940	0.1092	0.1346
Free Cash Flow	-	-	-113.3	-	-	-	-	-
FCF margin	-	-	-49.01%	-	-	-	-	-
FCF Conversion (EBITDA)	-	-	-	-	-	-	-	-
FCF Conversion (Net income)	-	-	-	-	-	-	-	-
Dividend per Share ²	0.0350	-	0.0440	0.0320	-	0.0121	0.0230	0.0325
Announcement Date	20-07-22	21-05-21	22-05-19	23-05-23	24-05-23	-	-	-

¹NZD in Million²NZD

Estimates

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	322	-	370	555	-	564	502	506
Net Cash position ¹	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	5.072 x	-	4.858 x	6.937 x	-	5.71 x	4.623 x	4.281 x
Free Cash Flow	-	-	-113	-	-	-	-	-
ROE (net income / shareholders' equity)	7.12%	-	6.86%	6.13%	-	7.1%	7.84%	7.27%
ROA (Net income/ Total Assets)	2.91%	-	3%	2.47%	2.65%	3.05%	2.05%	2.13%
Assets ¹	-467.3	-	2,040	625.4	1,190	2,104	4,519	4,958
Book Value Per Share ²	0.9600	-	1.340	1.340	-	1.510	1.630	1.760
Cash Flow per Share ²	0.1600	-	0.1500	0.1000	-	0.1300	0.1300	0.1400
Capex ¹	136	-	113	220	-	122	125	157
Capex / Sales	70.22%	-	48.67%	88.84%	-	40.59%	38.07%	45.14%
Announcement Date	20-07-22	21-05-21	22-05-19	23-05-23	24-05-23	-	-	-

¹NZD in Million²NZD

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.53 NZD

Average target price

0.9375 NZD

Spread / Average Target

+76.89%

	1st Jan change	Capi.
HCA HEALTHCARE, INC.	+18.69%	84.15B
CVS HEALTH CORPORATION	-25.20%	74.14B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+1.62%	26.92B
LABCORP HOLDINGS INC.	-10.46%	17.15B
FRESENIUS SE & CO. KGAA	-0.68%	16.83B
QUEST DIAGNOSTICS INCORPORATED	-0.73%	15.21B
NATERA, INC.	+72.88%	13.3B
TENET HEALTHCARE CORPORATION	+76.04%	12.99B
PURE HEALTH HOLDING	-25.79%	12.79B